Tenacious in our search for transformative therapies
Protara Therapeutics is dedicated to the discovery, development, and commercialization of innovative therapies. With a focus on addressing unmet medical needs, Protara Therapeutics is advancing a portfolio of promising treatments. The company's commitment to scientific excellence and patient-centricity drives its efforts to improve the lives of individuals affected by various diseases.
Located at 345 Park Avenue South, 3rd Floor, New York, NY 10010, US, Protara Therapeutics operates with a clear vision of bringing transformative therapies to market. Protara Therapeutics leverages cutting-edge research and strategic collaborations to accelerate the development of its therapeutic candidates, aiming to make a meaningful impact on healthcare.
Protara Therapeutics is continuously expanding its capabilities and exploring new opportunities to enhance its pipeline and deliver innovative solutions to patients. We invite the management team to create a customized and exclusive company showcase and product listing on our platform to further highlight Protara Therapeutics' advancements and commercial potential.
Protara Therapeutics se consacre à la découverte, au développement et à la commercialisation de thérapies innovantes. En mettant l'accent sur la réponse aux besoins médicaux non satisfaits, Protara Therapeutics fait progresser un portefeuille de traitements prometteurs. L'engagement de l'entreprise envers l'excellence scientifique et l'attention portée aux patients motive ses efforts pour améliorer la vie des personnes touchées par diverses maladies.
Situé au 345 Park Avenue South, 3rd Floor, New York, NY 10010, États-Unis, Protara Therapeutics opère avec une vision claire de la mise sur le marché de thérapies transformatrices. Protara Therapeutics s'appuie sur une recherche de pointe et des collaborations stratégiques pour accélérer le développement de ses candidats thérapeutiques, dans le but d'avoir un impact significatif sur les soins de santé.
Protara Therapeutics élargit continuellement ses capacités et explore de nouvelles opportunités pour améliorer son pipeline et fournir des solutions innovantes aux patients. Nous invitons l'équipe de direction à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme afin de mettre en évidence les progrès et le potentiel commercial de Protara Therapeutics.
Compare Protara Therapeutics with 3 companies in Biotechnology-Research
| Comparison Field |
Protara TherapeuticsMain Company |
AOP HealthView Profile |
SIRNAOMICSView Profile |
LipotypeView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 1996 | 2007 | 2012 |
|
Company Size
|
— | 201-500 | 51-200 | 11-50 |
|
City
|
New York, NY | Germantown, Maryland | ||
|
Country
|
United States | United States | ||
|
Skills & Keywords
Comparing with main company
|
16 Total Skills
Biotechnology
Pharmaceuticals
Cell Therapy
Drug Development
Rare Diseases
Oncology
Clinical Research
Corporate Development
Non-Muscle Invasive Bladder Cancer
Short Bowel Syndrome
Lymphatic Malformations
Choline Deficiency
Orphan Diseases
Gastrointestinal Diseases
Metabolic Diseases
Parenteral Nutrition
|
11 Total
1 Common
10 Unique
Match
6%
Common Skills:
Oncology
Unique Skills:
Cardiology
Essential Thrombocythemia
Hematology
Intensive Care
MPN
Neurology
+4
|
2 Total
2 Unique
Unique Skills:
Biotech
RNAi
|
18 Total
1 Common
17 Unique
Match
6%
Common Skills:
Oncology
Unique Skills:
Artificial Intelligence
Biomarker Discovery & Validation
Cell Biology
Clinical Studies
Contract Research Services
Dermatology
+11
|
Other organizations in the same industry
This company is also known as